Literature DB >> 8354656

Evolving risk factors for infectious complications of cancer therapy.

S Chanock1.   

Abstract

Advances in the supportive care of cancer patients have led to improved long-term outcomes. Infection, however, remains the most significant complication of cancer therapy. The author reviews the impact of new cancer therapies on the risk factors for infectious complications and the impact of therapy on the alterations in host defense. The relative importance of therapy-induced changes are contrasted with immunologic abnormalities associated with specific cancers. In addition, the author contrasts these changes with the infectious complications of human immunodeficiency virus infection, highlighting common themes in immunocompromised patients.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8354656

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  12 in total

Review 1.  Pneumonia in neutropenic patients.

Authors:  C P Heussel; H-U Kauczor; A J Ullmann
Journal:  Eur Radiol       Date:  2003-07-24       Impact factor: 5.315

2.  Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States.

Authors:  Veerajalandhar Allareddy; Sankeerth Rampa; Veerasathpurush Allareddy
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

3.  Fatal Infections Among Cancer Patients: A Population-Based Study in the United States.

Authors:  Yongqiang Zheng; Ying Chen; Kaixu Yu; Yun Yang; Xindi Wang; Xue Yang; Jiaxin Qian; Ze-Xian Liu; Bian Wu
Journal:  Infect Dis Ther       Date:  2021-03-24

Review 4.  Immune modulation in the treatment of respiratory infection.

Authors:  J K Kolls; S Nelson
Journal:  Respir Res       Date:  2000-06-23

5.  Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.

Authors:  Mark D Williams; Lee Ann Braun; Liesl M Cooper; Joseph Johnston; Richard V Weiss; Rebecca L Qualy; Walter Linde-Zwirble
Journal:  Crit Care       Date:  2004-07-05       Impact factor: 9.097

6.  Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.

Authors:  Ashham Mansur; Evelyn Mulwande; Maximilian Steinau; Ingo Bergmann; Aron Frederik Popov; Michael Ghadimi; Tim Beissbarth; Martin Bauer; José Hinz
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

7.  Outcomes of patients with systolic heart failure presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon.

Authors:  Gilbert Abou Dagher; Karim Hajjar; Christopher Khoury; Nadine El Hajj; Mohammad Kanso; Maha Makki; Aurelie Mailhac; Ralphe Bou Chebl
Journal:  BMJ Open       Date:  2018-08-01       Impact factor: 2.692

8.  Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.

Authors:  Miriam Diepold; Peter Noellke; Ulrich Duffner; Udo Kontny; Reinhard Berner
Journal:  BMC Infect Dis       Date:  2008-03-06       Impact factor: 3.090

9.  Oxidative stress level is not associated with survival in terminally ill cancer patients: a preliminary study.

Authors:  Chang Hwan Yeom; Youn Seon Choi; Hong Yup Ahn; Su Hey Lee; In Cheol Hwang
Journal:  BMC Palliat Care       Date:  2014-03-21       Impact factor: 3.234

10.  Are patients with cancer with sepsis and bacteraemia at a higher risk of mortality? A retrospective chart review of patients presenting to a tertiary care centre in Lebanon.

Authors:  Gilbert Abou Dagher; Christopher El Khuri; Ahel Al-Hajj Chehadeh; Ali Chami; Rana Bachir; Dina Zebian; Ralphe Bou Chebl
Journal:  BMJ Open       Date:  2017-03-13       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.